References

medsovet

Медицинский Совет

Meditsinskiy sovet = Medical Council

2079-701X2658-5790

REMEDIUM GROUP Ltd.

10.21518/2079-701X-2019-1-84-87

medsovet-2903

Research Article

ДИССЕРТАНТ

DISSERTANT

Возможности применения плазмы, обогащенной тромбоцитами, при заболеваниях и повреждениях крупных суставов

Therapeutic potential of platelet-rich plasma in diseases and injuries of the large joints

Айрапетов

Г. А.

Airapetov

G. A.

к.м.н., доцент кафедры травматологии и ортопедии Федерального государственного бюджетного образовательного учреждения высшего образования «Ставропольский государственный медицинский университет» Министерства здравоохранения Российской Федерации

Cand. of Sci. (Med.), Associate Professor of Chair of Traumatology and Orthopedics, Federal State Budgetary Educational Institution of Higher Education «Stavropol State Medical University» of the Ministry of Health of the Russian Federation

AirapetovGA@yandex.ru

Федеральное государственное бюджетное образовательное учреждение высшего образования «Ставропольский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Higher Education «Stavropol State Medical University» of the Ministry of Health of the Russian FederationRussian Federation

2019

05032019

018487

2019

Айрапетов Г.А.

Airapetov G.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-sovet.pro/jour/article/view/2903

Для лечения повреждений и заболеваний крупных суставов предложено много различных консервативных и оперативных методов. Небольшой костно-хрящевой дефект довольно быстро может увеличиться, а без должного лечения – привести к быстрому развитию остеоартрита. Хирургические методы лечения, такие как туннелизация, микрофрактурирование, мозаичная аутохондропластика и другие, можно улучшить, применяя экзогенные факторы роста. Одним из средств, которое содержит факторы, стимулирующие регенерацию, является плазма, обогащенная тромбоцитами (PRP). Обсуждается положительное воздействие PRP не только на хондрогенез в области дефектов гиалинового хряща, но и на проявления остеоартрита. Необходимо дальнейшее выяснение механизма воздействия плазмы и точной концентрации препарата.

Numerous non-surgical and surgical procedures have been proposed to treat injuries and diseases of the large joints. Any small bone and cartilage defect can progress quite quickly and cause osteoarthritis to develop in many joints without proper treatment. Surgical procedures include tunnelization, microfracturing, mosaic autochondroplasty, etc. The joint condition can be improved by using exogenous growth factors. Platelet-rich plasma (PRP) is one of the remedies that contain regeneration-stimulating factors. The article discusses the positive effects of PRP not only on chondrogenesis in the area of hyaline cartilage defects, but also on osteoarthritis. There is a need to further clarify the mechanism of action of plasma and the exact concentration of the preparation.

костно-хрящевой дефектрегенерацияплазмаPRPостеоартрит

bone and cartilage defectsregenerationplasmaPRPosteoarthritis

References1

Шевцов В.И., Макушин В.Д., Ступина Т.А., Степанов М.А. Экспериментальные аспекты изучения репаративной регенерации суставного хряща в условиях туннелирования субхондральной зоны с введением аутологичного костного мозга. Гений ортопедии. 2010; 2: 5-10.

Shevtsov V.I., Makushin V.D., Stupina T.A., Stepanov M.A. Experimental aspects of the study of reparative regeneration of articular cartilage under tunnelization of the subchondral zone with injection of autologous bone marrow. Geniy Ortopedii. 2010; 2: 5-10. (In Russ).

Solheim E., Hegna J., Oyen J., Harlem T., Strand T. Results at 10 to 14 years after osteochondralautografting (mosaicplasty) in articular cartilage defects in the knee. Knee. 2013; 20: 287– 290.

Welsch G.H., Mamisch T.C., Zak L., Blanke M., Olk A., Marlovits S., Trattnig S. Evaluation of cartilage repair tissue after matrix-associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen based scaffold with morphological MOCART scoring and biochemical T2 mapping: preliminary results. Am J Sports Med., 2010; 38(5): 934-942.

Kim M.K., Choi S.W., Kim S. R., Oh I.S., Won M.H. Autologous chondrocyte implantation the knee using fibrin. Knee Surg Sports Traumatol Arthrosc. 2010; 18(4): 528-534.

Benthien J.P., Behrens P. Autologous matrixinduced chondrogenesis (AMIC) combining microfracturing and a collagen i/iii matrix for articular cartilage resurfacing. Cartilage. 2010; 1: 65-68.

Dhollander A., Moens K., van der Maas J., Verdonk P., Almqvist K.F., Victor J. Treatment of Patellofemoral Cartilage Defects in the Knee by Autologous Matrix-Induced Chondrogenesis (AMIC). Acta Orthop. Belg. 2014; 80: 251-259.

Zhai L.J., Zhao K.Q., Wang Z.Q., Feng Y., Xing S.C. Mesenchymal stem cells display different gene expression profiles compared to hyaline and elastic chondrocytes. Int J Clin Exp Med. 2011; 4(1): 81-90.

Tanaka Y. Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis. Clin Exp Rheumatol. 2015; 33: 58-62.

Mesenchymal M. Influence of three-dimensional hyaluronic acid stem cell chondrogenesis. Gene Expr. 2009; 15: 243–254. doi:10.1089/ten. tea.2008.0067.

Pei M., Seidel J., Vunjak-Novakovic G., Freed L.E. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem. Biophys. Res. Commun. 2002; 294: 149–154. doi:10.1016/S0006-291X(02)00439-4.

Brandl A., Angele P., Roll C., Prantl L., Kujat R., Kinner B. Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J. Orthop. Res. 2010; 28: 354–360. doi:10.1002/jor.21007.

Duval E., Leclercq S., Elissalde J.-M., Demoor M., Galéra P., Boumédiene K. Hypoxia-inducible factor 1α inhibits the fibroblast-like markers type I and type III collagen during hypoxiainduced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alphadependent redifferentiation of chondrocytes. Arthritis Rheum. 2009; 60: 3038–3048.

doi:10.1002/ art.24851.

Markway B.D., Cho H., Johnstone B. Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes. Arthritis Res. Ther. 2013; 15: R92. doi:10.1186/ ar4272.

Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004; 91: 4-15.

Anitua E., Sanchez M., Nurden A.T., Nurden P., Orive G., Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006; 24: 227-234.

Bielecki T.M., Gazdzik T.S., Arendt J., Szczepanski T., Krol W., Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br. 2007; 89: 417-420.

Cervelli V., Gentile P., Grimaldi M. Regenerative surgery: Use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg. 2009; 33: 340-345.

Mazzocca A.D., McCarthy M.B.R., Chowaniec D.M., et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012; 94: 308–316.

Giusti I., Rughetti A., D’Ascenzo S. et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009; 49: 771–778.

McCarrel T.M., Minas T., Fortier L.A. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012; 94: e143.1–e143.8.

Andia I., Abate M. Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association? Expert Opin Biol Ther. 2014; 14(5): 635-649.

Milano G., Sanna Passino E., Deriu L. et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage. 2010; 18: 971– 980.

Qi Y.Y., Chen X., Jiang Y.Z. et al. Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair. Cell Transplant. 2009; 18: 1161–1169.

Sun Y., Feng Y., Zhang C.Q. et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010; 34: 589–597.

Egemen Altan, Kerem Aydin, Omer Erkocak, Hakan Senaran, Serdar Ugras. The effect of platelet-rich plasma on osteochondral defects treated with mosaicplasty. International Orthopaedics (SICOT). 2014; 38: 1321–1328. doi: 10.1007/s00264-013-2275-9.

Kon E., Filardo G., Delcogliano M. et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagenhydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010; 11: 220.

Serra C.I., Soler C., Carrillo J.M. et al. Effect of autologous platelet-rich plasma on the repair of full-thickness articular defects in rabbits. Knee Surg Sports Traumatol Arthrosc. 2013; 21: 1730–1736.

Khoshbin A., Leroux T., Wasserstein D. et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013; 29: 2037–2048.

Chang K.V., Hung C.Y., Aliwarga F. et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014; 95: 562–575.

Laudy A.B.M., Bakker E.W.P., Rekers M. et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015; 49: 657–672.

Patel S., Dhillon M.S., Aggarwal S., Marwaha N., Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41(2): 356-364.

Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015; 31: 2213–2221.

Riboh J.C., Saltzman B.M., Yanke A.B. et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2015.

pii:0363546515580787. [Epub ahead of print].

Маланин Д.А., Новочадов В.В., Демкин С.А. и соавт. Обогащенная тромбоцитами аутологичная плазма в лечении пациентов с гонартрозом III стадии. Травматология и ортопедия России. 2014;3(73):52-59.

Malanin D.A., Novochadov V.V., Demkin S.A. et al. Platelet-rich autologous plasma in the treatment of patients with stage III gonarthrosis. Travmatologiya i Ortopediya Rossii. 2014;3(73):52-59 (In Russ)

Filardo G., Kon E., Buda R., Timoncini A. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19:528–535. doi: 10.1007/s00167-010-1238-6.

Sanchez M., Anitua E., Orive G., Mujika I., Andia I. Platelet- rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39:345–354.

The authors declare that there are no conflicts of interest present.